Table 1.
Cohort characteristics
| Characteristics | Low C‐peptide | Preserved C‐peptide | P‐value |
|---|---|---|---|
| No. of participants | 151 | 70 | – |
| No. male (%) | 86 (57) | 29 (41) | 0.03* |
| Age at diagnosis (years) | 6.1 (3.0, 12.5) | 15.1 (12.2, 22.0) | < 0.0001 |
| Age at recruitment (years) | 19.9 (14.3, 36.5) | 30.9 (20.8, 42.1) | 0.0001 |
| BMI (kg/m²) | 23.3 (20.2, 26.5) | 25.2 (23.3, 27.3) | 0.0006 |
| BMI standard deviation score | 0.8 (0.1, 1.5) | 1.0 (0.5, 1.6) | 0.2 |
| Duration of diabetes (years) | 13.3 (8.5, 24.5) | 12.6 (7.5, 22.0) | 0.2 |
| C‐peptide (pmol/l) | <3 (<3, <3) | 114 (43, 273) | < 0.0001 |
| HbA1c (mmol/mol) | 67 (58, 76) | 69 (62, 81) | 0.6 |
| HbA1c (%) | 8.3 (7.5, 9.1) | 8.5 (7.8, 9.6) | 0.6 |
| Insulin dose (U/kg in 24 h) | 0.81 (0.67, 0.95) | 0.68 (0.54, 0.94) | 0.01 |
| No. in hypoglycaemia rate analysis (%) | 121 (80) | 39 (56) | – |
| No. in historic HbA1c analysis (%) | 86 (57) | 67 (96) | – |
Values are reported as n (%) or median (IQR). P‐values are Mann–Whitney U unless stated otherwise stated; *χ2.